Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary university hospital of Verona (northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 29 07 2019
revised: 02 12 2019
accepted: 11 12 2019
pubmed: 12 1 2020
medline: 2 10 2020
entrez: 12 1 2020
Statut: ppublish

Résumé

Klebsiella pneumoniae strain is an important opportunistic pathogen that causes severe nosocomial infections. In the present study a molecular characterization of carbapenem resistant K. pneumoniae, isolated from blood samples of hospitalized patients of Verona University Hospital, was performed. The simultaneous presence of SHV-1/CTX-M-15/KPC-3 and SHV-1/CTX-M-15/OXA-48 serin-β-lactamases was ascertained in the 89% and 11% of K. pneumoniae ST512 and K. pneumoniae ST14, respectively. Molecular characterization of bla genes showed that bla

Identifiants

pubmed: 31924425
pii: S0732-8893(19)30766-7
doi: 10.1016/j.diagmicrobio.2019.114968
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-lactamase CTX-M-15 EC 3.5.2.-
beta-Lactamases EC 3.5.2.6
beta-lactamase KPC-3, Klebsiella pneumoniae EC 3.5.2.6
oxacillinase EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114968

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None to declare.

Auteurs

Alessandra Piccirilli (A)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Mariagrazia Perilli (M)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy. Electronic address: perilli@univaq.it.

Valentina Piccirilli (V)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Bernardetta Segatore (B)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Gianfranco Amicosante (G)

Dipartimento di Scienze Cliniche Applicate e Biotecnologiche, Università degli Studi dell'Aquila, L'Aquila, Italy.

Laura Maccacaro (L)

U.O.C. di Microbiologia e Virologia, Dipartimento di Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

Alda Bazaj (A)

Dipartimento di Diagnostica e Sanità Pubblica, Università di Verona, Verona, Italy.

Laura Naso (L)

U.O.C. di Microbiologia e Virologia, Dipartimento di Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

Giuliana Lo Cascio (GL)

U.O.C. di Microbiologia e Virologia, Dipartimento di Patologia e Diagnostica, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.

Giuseppe Cornaglia (G)

Dipartimento di Diagnostica e Sanità Pubblica, Università di Verona, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH